The Trump administration is considering a dramatic cutback and eventual phasing out of the President’s Emergency Plan for ...

LONDON -- The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, ...

Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer screenings and other ...

(Reuters) -Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Experts welcome the news that PEPFAR funding remains intact, but few details about how and where services will be ...

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

Gilead Sciences (GILD) stock gains as Needham upgrades the company to Buy from Hold citing its new HIV prevention injectable, ...

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

A federal judge on Thursday extended a temporary legal block that prevents Idaho from verifying the immigration status of ...

Fourth District Judge Amanda Brailsford in Boise on Thursday also granted provisional class-action status to a lawsuit ...